HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rock, M. T. Articles by Crowe, J. E. Search for Related Content PubMed PubMed Citation Articles by Rock, M. T. Articles by Crowe, J. E., Jr

Differential Regulation of Granzyme and Perforin in Effector and Memory T Cells following Smallpox Immunization¹

Michael T. Rock^*, Sandra M. Yoder^*, Peter F. Wright^*,, Thomas R. Talbot, Kathryn M. Edwards^* and James E. Crowe, Jr^2,*,

Departments of ^* Pediatrics, Microbiology and Immunology, and Medicine, Vanderbilt University Medical Center, Nashville, TN 37232

Primary immunization of healthy adults with vaccinia virus induces a local vesicle or "take" in the majority of vaccinees that previously has been shown to correlate with protection against smallpox. However, the immunologic mechanisms underlying this protective response in humans are not well characterized. We have studied human CD8⁺ T cells for the expression patterns of phenotypic markers and cytolytic effector molecules before and after primary smallpox immunization using nine-color polychromatic flow cytometry. One month after immunization, vaccinees developed vaccinia virus-specific CD8⁺ T cells with an effector cell phenotype containing both granzyme A and granzyme B. One year after immunization, we found a significant decrease in granzyme B containing cells and an increased memory cell phenotype in virus-specific CD8⁺ T cells. Perforin was rarely expressed directly ex vivo, but was highly expressed after Ag-specific activation in vitro. Together, these data suggest an important role for effector CD8⁺ T cells in controlling poxvirus infection, and have implications for our understanding of human CD8⁺ T cell differentiation.

This article has been cited by other articles:

				M. Hutchens, K. E. Luker, P. Sottile, J. Sonstein, N. W. Lukacs, G. Nunez, J. L. Curtis, and G. D. Luker TLR3 Increases Disease Morbidity and Mortality from Vaccinia Infection J. Immunol., January 1, 2008; 180(1): 483 - 491. [Abstract] [Full Text] [PDF]

				J. J. Zaunders, W. B. Dyer, M. L. Munier, S. Ip, J. Liu, E. Amyes, W. Rawlinson, R. De Rose, S. J. Kent, J. S. Sullivan, et al. CD127+CCR5+CD38+++ CD4+ Th1 Effector Cells Are an Early Component of the Primary Immune Response to Vaccinia Virus and Precede Development of Interleukin-2+ Memory CD4+ T Cells. J. Virol., October 1, 2006; 80(20): 10151 - 10161. [Abstract] [Full Text] [PDF]

				H. Takata and M. Takiguchi Three Memory Subsets of Human CD8+ T Cells Differently Expressing Three Cytolytic Effector Molecules J. Immunol., October 1, 2006; 177(7): 4330 - 4340. [Abstract] [Full Text] [PDF]

				N. Jacobs, R. A.-J. Chen, C. Gubser, P. Najarro, and G. L. Smith Intradermal immune response after infection with Vaccinia virus. J. Gen. Virol., May 1, 2006; 87(Pt 5): 1157 - 1161. [Abstract] [Full Text] [PDF]